Acumen LLC, United States
Disclosure information not submitted.
Assessment of Potential Adverse Events Following the 2022–2023 Seasonal Influenza Vaccines Among U.S. Adults Aged 65 Years and Older
Monday, August 26, 20242:30 PM – 2:45 PM CEST